Potential molecular prognostic markers in head and neck squamous cell carcinomas.
about
Metallopanstimulin as a marker for head and neck cancerCysteine proteinase inhibitor cystatin C in squamous cell carcinoma of the head and neck: relation to prognosisThe future of laryngology.Pituitary tumor-transforming gene expression is a prognostic marker for tumor recurrence in squamous cell carcinoma of the head and neck.The immunosuppressive surface ligand CD200 augments the metastatic capacity of squamous cell carcinoma.Protein secretion in human mammary epithelial cells following HER1 receptor activation: influence of HER2 and HER3 expression.Combination of phosphorylated and truncated EGFR correlates with higher tumor and nodal stage in head and neck cancerHistopathological variants of cutaneous squamous cell carcinoma: a review.Human papillomavirus infection and cyclin D1 gene amplification in laryngeal squamous cell carcinoma: biologic function and clinical significance.Potential molecular prognostic markers for lymph node metastasis in head and neck squamous cell carcinoma.Dynamic contrast-enhanced magnetic resonance imaging as a predictor of outcome in head-and-neck squamous cell carcinoma patients with nodal metastasesEGFR expression in advanced head and neck cutaneous squamous cell carcinoma.Opportunities and challenges facing biomarker development for personalized head and neck cancer treatment.Genome-wide identification of novel expression signatures reveal distinct patterns and prevalence of binding motifs for p53, nuclear factor-kappaB and other signal transcription factors in head and neck squamous cell carcinoma.Signal transducers and activators of transcription: insights into the molecular basis of oral cancer.Molecular analyses of unselected head and neck cancer cases demonstrates that human papillomavirus transcriptional activity is positively associated with survival and prognosis.Constitutive activation of Stat3 signaling pathway in human colorectal carcinoma.Impact of EGFR and p53 expressions on survival and quality of life in locally advanced oral squamous cell carcinoma patients treated with chemoradiationIntegrins in head and neck squamous cell carcinoma (HNSCC): a review of the current literature.Targeting HER1/EGFR in cancer therapy: experience with erlotinib.Vascular endothelial growth factor-A and Poly(A) binding protein-interacting protein 2 expression in human head and neck carcinomas: correlation and prognostic significance.Diagnosis and therapy of oral squamous cell carcinoma.Heparanase induces VEGF C and facilitates tumor lymphangiogenesis.Ron tyrosine kinase receptor synergises with EGFR to confer adverse features in head and neck squamous cell carcinoma.Id2 regulates the proliferation of squamous cell carcinoma in vitro via the NF-κB/Cyclin D1 pathway.Dysregulated molecular networks in head and neck carcinogenesisEvaluation of Tissue Expression and Salivary Levels of HER2/neu in Patients with Head and Neck Squamous cell CarcinomaSUMOylation and SENP3 regulate STAT3 activation in head and neck cancer.Predicting response to radiotherapy: evolutions and revolutions.Head and neck cancer: from anatomy to biology.Prognostic molecular markers in head and neck squamous cell carcinoma in a New Zealand population: matrix metalloproteinase-2 and sialyl Lewis x antigen.Differences in the expression of genes between normal tissue and squamous cell carcinomas of head and neck using cancer-related gene cDNA microarray.Expression of epidermal growth factor receptor (EGFR) and Ki67 in feline oral squamous cell carcinomas (FOSCC).Antiangiogenic antibody improves melanoma detection by fluorescently labeled therapeutic antibodies.Evaluation of Cyclin D1 expression in Head and Neck Squamous Cell Carcinoma.Interleukin-6 signalling regulates vascular endothelial growth factor-C synthesis and lymphangiogenesis in human oral squamous cell carcinoma.The roles of JNK1 and Stat3 in the response of head and neck cancer cell lines to combined treatment with all-trans-retinoic acid and 5-fluorouracil.Quantitative real-time PCR identifies a critical region of deletion on 22q13 related to prognosis in oral cancer.Biomarker discovery and identification in laser microdissected head and neck squamous cell carcinoma with ProteinChip technology, two-dimensional gel electrophoresis, tandem mass spectrometry, and immunohistochemistry.The sensitivity of head and neck carcinoma cells to statins is related to the expression of their Ras expression status, and statin-induced apoptosis is mediated via suppression of the Ras/ERK and Ras/mTOR pathways.
P2860
Q24557517-9BD829D2-25F5-4710-979D-B764A898DF41Q24646038-0A9876CA-BBB9-417A-A7E5-07F9E5A3E1CDQ30767260-D4BC5B55-4CB1-45FE-A29A-7DB8AE356FE7Q33259832-8A2181BC-AFC5-4670-A0BC-465290C396B4Q33767115-DF79D068-4A67-4060-98BF-F981C346EC1DQ33820267-8FE8D5BA-FF40-4772-881A-C8F6A41AD1EAQ34318204-4D5CD1D3-0FBC-404D-B7E7-0E06A31A6C97Q34479227-0E2803CE-6025-4675-9AB1-F621F21416C5Q34733433-A3AC550E-4B85-42BF-B07B-321D408F6F32Q35081020-D7AB09D5-D9F1-40C1-8075-BC36265E1EDDQ35223964-7D1ED1E0-034C-4659-8C34-7E7D62F1A8CDQ35353893-C1396163-BA04-4FE6-8972-734D2F175F15Q35673572-04721A53-008C-42A9-BAC7-CCC2B7C12B2DQ35906476-F2C12140-C734-440F-A1A7-95F08D19F326Q35911353-D9A78E49-4EC2-4078-BFAD-887C6C90E213Q36050759-DC0866EE-4A50-456F-8469-D9CD9E88BA8CQ36067474-36BD42BA-AE4E-4579-83C2-7CCBB59F35C7Q36213310-8DA680C2-71AF-4FEB-9A8F-29C634C4B5C8Q36349943-7459CB9D-395B-4B1E-8C03-ED65CA01C9A7Q36429516-85A8E1BC-EE61-4FCE-B73E-1F6D847F6266Q36614158-22346B8D-B23C-465C-B0AD-E263D65869BBQ36752033-DBA944E2-8F23-4C98-990F-E45495D98F58Q36953862-57D205BC-C0C9-4FF7-B064-2F087A707C87Q37040636-3FBD7AFD-CB0E-4107-8270-8AE9660CAA18Q37183729-75C6CAA2-052C-422C-B742-912B614E1752Q37274623-BA9DD5A6-9848-424E-AFEC-AED8ED73F607Q37355025-CFD6C45B-7CD7-420D-8C53-7D9DDE48791CQ37423674-3CD77C60-1C71-453F-BEFC-FC8E8B16BFC5Q37622879-B3ED1802-F4A3-42A4-B330-7D28B64129D7Q38082457-CB0CE7C4-C67F-439E-AB28-DCE5C20A5247Q38156480-A1658A60-96B1-43C2-B3D7-A39DE14E8232Q38311247-F1D8494D-12CB-4E16-AA1D-CC2BF7D0EFB0Q38410351-4CC5B7BE-A222-4C6A-BD0E-77A9F872A783Q38748970-F6628AC9-6878-4DC6-8DA6-17A7D2B252A0Q38849727-BB11B9BE-2134-4988-B235-69A459774710Q39516781-8A995D0B-1BBD-4F72-A81C-AEEC54DBC4F7Q40741027-47DF34F2-290F-48AD-BB96-0EEC5F0C709DQ44134120-A420B3B5-5658-445B-916B-38BCFA371024Q47388450-19FA569D-D281-466D-B71C-1A105D719D32Q50225058-3806BEBF-2C34-4D17-89DB-3AB60BE37215
P2860
Potential molecular prognostic markers in head and neck squamous cell carcinomas.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Potential molecular prognostic markers in head and neck squamous cell carcinomas.
@ast
Potential molecular prognostic markers in head and neck squamous cell carcinomas.
@en
Potential molecular prognostic markers in head and neck squamous cell carcinomas.
@nl
type
label
Potential molecular prognostic markers in head and neck squamous cell carcinomas.
@ast
Potential molecular prognostic markers in head and neck squamous cell carcinomas.
@en
Potential molecular prognostic markers in head and neck squamous cell carcinomas.
@nl
prefLabel
Potential molecular prognostic markers in head and neck squamous cell carcinomas.
@ast
Potential molecular prognostic markers in head and neck squamous cell carcinomas.
@en
Potential molecular prognostic markers in head and neck squamous cell carcinomas.
@nl
P2093
P2860
P1433
P1476
Potential molecular prognostic markers in head and neck squamous cell carcinomas.
@en
P2093
P2860
P304
P356
10.1002/1097-0347(200102)23:2<147::AID-HED1010>3.0.CO;2-#
P577
2001-02-01T00:00:00Z